M. Fitzgerald

发表

Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.

Andrew C Good, Maria Fitzgerald, A. Good, 2012, Journal of medicinal chemistry.

CSF1R signaling is a regulator of pathogenesis in progressive MS

O. Butovsky, A. Mahan, Barbara Gisevius, 2020, Cell Death & Disease.

Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.

J. Clardy, Ralph Mazitschek, J. Cortese, 2010, Bioorganic & medicinal chemistry letters.

Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.

J. McDonald, Beatriz Ospina, J. Murtie, 2020, ACS medicinal chemistry letters.

The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.

A. Good, R. Wei, H. Biemann, 2011, Bioorganic & medicinal chemistry letters.

Discovery of novel sphingosine kinase-1 inhibitors. Part 2.

Y. Xiang, M. Booker, B. Hirth, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and in vitro DMPK profiling of a 1,2-dioxolane-based library with activity against Plasmodium falciparum.

J. Clardy, J. Cortese, B. Liang, 2009, Bioorganic & medicinal chemistry letters.

Lead optimization attrition analysis (LOAA): a novel and general methodology for medicinal chemistry.

Mark Munson, Harvey Lieberman, Elina Tserlin, 2015, Drug discovery today.

A high-throughput glutathione trapping assay with combined high sensitivity and specificity in high-resolution mass spectrometry by applying product ion extraction and data-dependent neutral loss.

Qingping Wang, Chuang Lu, M. Fitzgerald, 2019, Journal of mass spectrometry : JMS.